Bioventus (BVS) Cash & Equivalents Growth (1y) (2021 - 2026)
Bioventus (BVS) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 72.43% |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | -10.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -10.49% |
| Mar 28, 2026 | 57.21% |
| Dec 31, 2025 | 23.22% |
| Sep 27, 2025 | -2.11% |
| Jun 28, 2025 | 2.86% |
| Mar 29, 2025 | -9.42% |
| Dec 31, 2024 | 12.49% |
| Sep 28, 2024 | 60.56% |
| Jun 29, 2024 | 8.86% |
| Mar 30, 2024 | -46.56% |
| Dec 31, 2023 | 22.45% |
| Sep 30, 2023 | -21.92% |
| Jul 1, 2023 | -28.32% |
| Apr 1, 2023 | 72.07% |
| Dec 31, 2022 | -31.29% |
| Oct 1, 2022 | -73.76% |
| Jul 2, 2022 | -70.30% |
| Apr 2, 2022 | -78.85% |
| Dec 31, 2021 | -49.41% |
| Oct 2, 2021 | 80.63% |